| 1. |
De Ligt J, Willemsen MH, Van Bon BWM, et al Diagnostic exome sequencing in persons with severe intellectual disability. New England Journal of Medicine, 2012, 367(20): 1921-1929.
|
| 2. |
|
| 3. |
Blanchet P, Bebin M, Bruet S, et al MYT1L mutations cause intellectual disability and variable obesity by dysregulating gene expression and development of the neuroendocrine hypothalamus. PLoS genetics, 2017, 13(8): e1006957.
|
| 4. |
Loid P, Mäkitie R, Costantini A, et al A novel MYT1L mutation in a patient with severe early‐onset obesity and intellectual disability. American Journal of Medical Genetics Part A, 2018, 176(9): 1972-1975.
|
| 5. |
|
| 6. |
Chen J, Yen A, Florian CP, et al MYT1L in the making: emerging insights on functions of a neurodevelopmental disorder gene. Translational Psychiatry, 2022, 12(1): 292.
|
| 7. |
Pekeles H, Accogli A, Boudrahem-Addour N, et al Diagnostic yield of intellectual disability gene panels. Pediatric Neurology, 2019, 92: 32-36.
|
| 8. |
Mayo S, Roselló M, Monfort S, et al Haploinsufficiency of the MYT1L gene causes intellectual disability frequently associated with behavioral disorder. Genetics in Medicine, 2015, 17(8): 683-684.
|
| 9. |
|
| 10. |
Weigel B, Tegethoff JF, Grieder S D, et al MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention. Molecular Psychiatry, 2023, 28(5): 2122-2135.
|
| 11. |
Kepa A, Martinez Medina L, Erk S, et al Associations of the intellectual disability gene MYT1L with helix–loop–helix gene expression, hippocampus volume and hippocampus activation during memory retrieval. Neuropsychopharmacology, 2017, 42(13): 2516-2526.
|
| 12. |
Prakasam R, Determan J, Narasimhan M, et al Autism and intellectual disability-associated myt1l mutation alters human cortical interneuron differentiation, maturation, and physiology. BioRxiv, 2024, 9: 612541.
|
| 13. |
Yen A, Sarafinovska S, Chen X, et al MYT1L deficiency impairs excitatory neuron trajectory during cortical development. Nature Communications, 2024, 15(1): 10308.
|
| 14. |
Wöhr M, Fong WM, Janas J A, et al Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice. Molecular Autism, 2022, 13(1): 19.
|
| 15. |
Carvalho LML, D’Angelo CS, Mustacchi Z, et al A novel MYT1L mutation in a boy with syndromic obesity: case report and literature review. Obesity Research & Clinical Practice, 2021, 15(2): 124-132.
|
| 16. |
Coursimault J, Guerrot AM, Morrow MM, et al MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Human Genetics, 2022, 32: 1-16.
|
| 17. |
Windheuser IC, Becker J, Cremer K, et al Nine newly identified individuals refine the phenotype associated with MYT1L mutations. American Journal of Medical Genetics (Part A), 2020, 182(5): 1021-1031.
|
| 18. |
Boeri S, Scala M, Madia F, et al MYT1L variant inherited by a mosaic father in a case of severe developmental and epileptic encephalopathy. Epileptic Disorders, 2023, 25(6): 874-879.
|
| 19. |
Yip S, Calli K, Qiao Y, et al Complex autism spectrum disorder in a patient with a novel de novo heterozygous MYT1L variant. Genes, 2023, 14(12): 2122.
|
| 20. |
|
| 21. |
|
| 22. |
|
| 23. |
|
| 24. |
Fahim I, Ishaque A, Ramzan F, et al Overexpression of OLIG2 and MYT1L transcription factors enhance the differentiation potential of human mesenchymal stem cells into oligodendrocytes. Current Issues in Molecular Biology, 2023, 45(5): 4100-4123.
|
